The drug industry is scrambling to bring psychedelic medicines to the market after Australia became the first country to approve their use, with on company offering free MDMA assisted therapy to first responders. MDMA, commonly known as ecstasy, has previously shown promising signs in clinical trials, however researchers have highlighted the potential risks as the drug begins to roll out more broadly.